Detection of undiagnosed diabetes and other hyperglycemia states: The atherosclerosis risk in communities study

Diabetes Care

Volumn 26, Issue 5, 2003, Pages 1338-1343

  Schmidt, Maria Ines ^a,b   Duncan, Bruce B ^a,b   Vigo, Alvaro ^a   Pankow, James ^c   Ballantyne, Christie M ^d   Couper, David ^b   Brancati, Frederick ^e   Folsom, Aaron R ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; SCREENING TEST;

AGED; BLOOD GLUCOSE; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROBABILITY; UNITED STATES;

EID: 0042168852     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.5.1338     Document Type: Article

References (24)

1. Venkat NK, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F: Diabetes: a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 50 (Suppl. 2): S77-S84, 2000
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
4. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
5. American Diabetes Association: The prevention or delay of type 2 diabetes. Diabetes Care 25:742-749, 2002
6. Qiao Q, Tuomilehto J: Diagnostic criteria of glucose intolerance and mortality. Minerva Med 92:113-119, 2001
7. The DECODE study group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria: European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet 354:617-621, 1999
8. Stem MP, Fatehi P, Williams K, Haffner SM: Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 25:1851-1856, 2002
9. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care 25:1845-1850, 2002
10. ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 129:687-702, 1989
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
12. Campbell G: Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med 13:499-508, 1994
13. Szklo M, Nieto FJ: Epidemiology: Beyond the Basics. Gaithersburg, MD, Aspen Publishers, 2000
14. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
15. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP: Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796-2803, 2002
16. Tuomilehto J. Point: a glucose tolerance test is important for clinical practice (Commentary). Diabetes Care 25:1880-1882, 2002
17. Davidson MB: Counterpoint: the oral glucose tolerance test is superfluous (Commentary). Diabetes Care 25:1883-1885, 2002
18. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ: Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22:213-219, 1999
19. Herman WH, Smith FJ, Thompson TJ, Engelgau MM, Aubert RE: A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18:382-387, 1995
20. Tabaei BP, Herman WH: A multivariate logistic regression equation to screen for diabetes: development and validation. Diabetes Care 25:1999-2003, 2002
21. Barriga KJ, Hamman RF, Hoag S, Marshall JA, Shetterly SM: Population screening for glucose intolerant subjects using decision tree analyses. Diabetes Res Clin Pract 34 (Suppl.):S17-S29, 1996
22. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ: Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164-171, 2000
23. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575-581, 2002
24. Hunt KJ, Williams K, Haffner SM, Stem MP: Predicting impaired glucose tolerance (IGT) among individuals with a nondiabetic fasting glucose value: the San Antonio Heart Study (Abstract). Diabetes 51 (Suppl. 2):A229, 2002